COM:AKEBIA
Akebia Therapeutics, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biopharmaceuticalwebsite
akebia.comcrunchbase
akebia-therapeuticslinkedin
akebia-therapeuticsfounding date
Jan 01, 2007ipo date
Mar 20, 2014
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dia...Show More